Expanding Access Through Responsibility and Partnership

Ivermectin has long been recognized as a safe and trusted treatment across a range of parasitic conditions. Yet despite its medical value, millions still lack access due to pricing, distribution limitations, and regulatory hurdles. We believe this is an unacceptable inequality.

We’re working to change that—by promoting affordability, ensuring ethical sourcing, and partnering with global stakeholders to strengthen distribution networks. Our commitment is to public health, and to the principle that no one should be denied access to essential medicines based on where they live or how much they earn.